{
  "figure_1": "Skin crew outreach was conducted across oregon. Outreach to skin‐aware professionals was conducted in locations throughout Oregon with the green pins indicating locations where schools/businesses were invited to participate in the Skin Crew and the blue shaded areas indicating the zip codes where Oregon skin crew members are located.",
  "figure_2": "The Level of Concern for Concerning and Nonconcerning Lesions was Assessed. Images from pretraining (top row, A–D), posttraining (middle row, E–H), and follow‐up (bottom row, I–L) surveys. Each image included the prompt: “How concerned are you that this should be seen by a doctor or nurse?” Correct answers were as follows: (A) Extremely concerning (B) Extremely concerning (C) Slightly/Somewhat concerning (D) Extremely concerning (E) Extremely concerning (F) Slightly/Somewhat concerning (G) Extremely concerning (H) Extremely concerning (I) Extremely concerning (J) Slightly/Somewhat concerning K) Extremely concerning (L) Extremely concerning.",
  "figure_3": "Social Media Ads Garnered the Majority of Website Visits. Daily Skin Crew page‐views on Startseeingmelanoma.com in 2022. This line graph represents the daily number of page‐views from January to December, annotated with key campaign events. Peaks in traffic coincide with specific promotional strategies: (1) Distribution of postcards, (2–4, 7) Sending of mass emails, (3, 5, 9) Deployment of top advertisements, (6, 8) Periods of increased advertising spend, (10) End of the campaign. The social media campaign occurred from March to October. Each numbered event corresponds to an increase in web traffic, indicative of the promotional impact on visitor engagement. The legend to the right show examples of promotional materials used at various stages, illustrating the diversity of approaches in the outreach campaign.",
  "figure_5": "Respondents Reported an Accurate Level of Concern for Most Skin Cancers. Pre‐test, post‐test, and follow‐up test performance on each image‐based question shown in Figure 2 were measured in survey respondents who were matched across all three surveys (n = 121) and matched based on the following lesion severities: Benign lesions (C, F, J), nonmelanoma skin cancers (B, H, I), pigmented lesions and melanomas (A, E, L), and melanomas (D, G, K). The bar highlighted in green represents the correct answer choice and expert's level of concern for each lesion."
}